Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for periprosthetic bone loss after TKA
NCT02760979Phase 4Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jan 2013
- Primary completion
- Jan 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 4 trial of denosumab in Bone resorption, sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Started Jan 2013; status: completed.
02
Drugs
denosumab
03
Conditions
Bone resorption
Beyond the preview
Go deeper on NCT02760979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02760979.